Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
Pancreatic cancer is a complex disease accounting for fibrotic tumors and an aggressive
phenotype. Gemcitabine (GEM) is used as a standard therapy, which develops …
phenotype. Gemcitabine (GEM) is used as a standard therapy, which develops …
Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer.
S Khan, S Setua, S Kumari, N Dan, A Massey… - Biomaterials, 2019 - europepmc.org
Pancreatic cancer is a complex disease accounting for fibrotic tumors and an aggressive
phenotype. Gemcitabine (GEM) is used as a standard therapy, which develops …
phenotype. Gemcitabine (GEM) is used as a standard therapy, which develops …
[PDF][PDF] Superparamagnetic Iron Oxide Nanoparticles of Curcumin Enhance Gemcitabine 1 Therapeutic Response in Pancreatic Cancer 2
S Khan, S Setua, S Kumari, N Dan, A Massey… - 2019 - academia.edu
Abstract 1 Pancreatic cancer is a complex disease accounting for fibrotic tumors and an
aggressive 2 phenotype. Gemcitabine (GEM) is used as a standard therapy, which develops …
aggressive 2 phenotype. Gemcitabine (GEM) is used as a standard therapy, which develops …
Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
S Khan, S Setua, S Kumari, N Dan, A Massey… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer is a complex disease accounting for fibrotic tumors and an aggressive
phenotype. Gemcitabine (GEM) is used as a standard therapy, which develops …
phenotype. Gemcitabine (GEM) is used as a standard therapy, which develops …